期刊文献+

维生素D对活动期系统性红斑狼疮患者内皮祖细胞的影响 被引量:1

Effects of vitamin D on endothelial progenitor cells from patients with active systemic lupus erythematosus
下载PDF
导出
摘要 目的:观察活动期系统性红斑狼疮(SLE)患者内皮祖细胞(EPCs)数量及功能的变化,并探讨维生素D对SLE患者EPCs数量及功能的影响.方法:收集30例SLEDAI评分大于8分,病情均处于活动期的SLE患者,30例年龄与性别匹配的健康人作为正常对照;酶联免疫吸附试验(ELISA)检测外周血25羟基维生素D[25(OH)D]水平;密度梯度离心和贴壁培养法分离培养EPCs,流式细胞术检测CD34^+/VEGFR-2^+EPCs在全血中的比例;通过计数再贴壁和构建侵袭小室检测EPCs黏附和迁移能力.结果:(1)体外培养过程中,活动期SLE患者EPCs数量(0.028±0.017)%显著低于正常对照组(0.067±0.012)%,有统计学差异(P<0.05);(2)活动期SLE患者EPCs迁移率(1.7±0.9)‰及黏附能力(19±7)显著低于正常对照组EPCs迁移率(3.1±1.6)‰及黏附能力(34±11),有统计学差异(P<0.05);(3)活动期SLE患者外周血25(OH)D质量浓度(14.47±10.39)ng/mL水平低于健康对照组质量浓度(24.15±7.98)ng/mL,有统计学差异(P<0.05);(4)25(OH)D能够增加活动期SLE患者EPCs数量(0.045±0.012)%,高于未加25(OH)D组(0.031±0.012)%,有统计学差异(P<0.05);(5)25(OH)D能够增加活动期SLE患者EPCs迁移率(2.6±0.7)‰及黏附能力(24±9),高于未加25(OH)D组迁移率(1.3±0.8)‰及黏附能力(13±6),有统计学差异(P<0.05).结论:SLE患者维生素D水平降低,可诱发Ⅰ型干扰素通路活化,从而导致EPCs数量和/或功能异常,最终造成狼疮患者血管内皮损伤后修复障碍引发动脉粥样硬化. Objective: To investigate the effects of vitamin D on Endothelial Progenitor Cells from patients with active systemic lupus erythematosus. Methods: Thirty consecutive patients( SLEDAI score≥8) in the active phase of SLE,also in-patients of our Hospital,aged 30 years,were included in the study,and a group of sex-matched healthy people was used as a control. Enyme linked immune sorbent assay( ELISA) was used to determine the level of 25-dihydroxyvitamin D[25( OH) D] in the peripheral blood. Endothelial progenitor cells( EPCs) were isolated by density gradient centrifugation and cultured.CD34^+/VEGFR-2^+EPCs ratios were analyzed by Flow cytometry. Migration and adhesion of EPCs wereobserved by transwell migration assay. Statistical analysis was conducted with t-test and Mann-Whitney rank test. Results:(1) In active SLE subgroups,the number of EPCs( 0. 028 ± 0. 017) % were significantly lower than the normal control( 0. 067 ± 0. 012) %( P < 0. 05).(2) The migration rate of EPCs from the active SLE patients( 1. 7 ± 0. 9) ‰ was significantly reduced as compared to the normal control( 3. 1 ± 1. 6) ‰( P < 0. 05). Adhesion of EPCs from the active SLE patients( 19 ± 7) was declined as compared to the normal control( 34 ± 11)( P < 0. 05).(3) The level of peripheral blood 25( OH) D in patients with active SLE( 14. 47 ± 10. 39) ng/ml was lower than the normal control( 24. 15 ±7. 98) ng/mL( P < 0. 05).(4) 25( OH) D caused a significant increase in cell number( 0. 045 ±0. 012) % of EPCs from the active SLE patients compared to the untreated cells( 0. 031 ± 0. 012) %( P < 0. 05).(5)25( OH) D caused a significant increase in cell migration( 2. 6 ± 0. 7) ‰ and adhesion( 24 ± 9) of EPCs from the active SLE patients compared to those of untreated cells,which were( 1. 3 ±0. 8) ‰ and( 13 ± 6),respectively( P < 0. 05). Conclusion: Both number and function of EPCs were significantly decreased in SLE patients. Vitamin D may be involved in reduction and dysfunction of EPCs in SLE.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2017年第6期543-547,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 新疆维吾尔自治区自然科学基金资助项目(2015211C109)
关键词 红斑狼疮 系统性 内皮祖细胞 维生素D lupus erythematosus systemic endothelial progenitor cells 25-dihydroxyvitamin D
  • 相关文献

参考文献3

二级参考文献19

  • 1陈治中,卿吉琳,胡丽华.Interactions of Human T Cell Immunoglobin Mucins with Apoptotic Cells[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2012,32(1):9-16. 被引量:2
  • 2Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the framingham study. Am J Epidemiol, 1997, 145: 408-415.
  • 3Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimalmedial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke, 1993, 24: 1297-1304.
  • 4Borhani NO, Mercuri M, Borhani PA, et al. Final outcome results of the Muhicenter lsradipine Diuretic Atherosclerosis Study (MIDAS).JAMA, 1996, 276: 785-791.
  • 5Urowitz MB, Bookman AA, Koehler BE, et al. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med, 1976,60: 221-225.
  • 6Roman M J, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med, 2003, 349: 2399-2406.
  • 7Manzi S, Seizer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum, 1999, 42:51-60.
  • 8Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis, 2003, 62: 1071-1077.
  • 9Jimenez S, Garcia-Criado MA, Tassies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford), 2005, 44: 756-761.
  • 10Expert Panel on Detection,Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). JAMA, 2001, 285: 2486-2497.

共引文献19

同被引文献13

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部